Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01844388 · ClinicalTrials.gov registry record · Phase 3
A Study to Compare a New Eye Drop Formulation With Refresh Contacts®
A Phase 3 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 3
- Development phase
- 365
- Enrollment target
NCT01844388 is a Phase 3 study that has completed, run by Allergan. The registered enrollment target is 365 participants.
The verdict
NCT01844388, a Phase 3 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 365 participants
- Enrollment target
Study Summary
This study will compare the safety and efficacy of a new carboxymethylcellulose based eye drop formula to Refresh Contacts® for lubricating and rewetting contact lenses.
Interventions
- DRUG carboxymethylcellulose based eye drop formula
- DRUG carboxymethylcellulose sodium based eye drop solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 365 participants |
| Start Date | 2013-05-29 |
| Est. Completion | 2013-12-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01844388
The ClinicalTrials.gov registry entry for NCT01844388 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 365 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which carboxymethylcellulose based eye drop formula is the first listed.
NCT01844388 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01844388 about?
NCT01844388 is a clinical study titled "A Study to Compare a New Eye Drop Formulation With Refresh Contacts®". This study will compare the safety and efficacy of a new carboxymethylcellulose based eye drop formula to Refresh Contacts® for lubricating and rewetting contact lenses.
What is the current status of trial NCT01844388?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 365 participants. The study started on 2013-05-29. Estimated completion is 2013-12-02.
What interventions are being tested in trial NCT01844388?
The interventions under investigation include: carboxymethylcellulose based eye drop formula (DRUG), carboxymethylcellulose sodium based eye drop solution (DRUG).
Who is sponsoring clinical trial NCT01844388?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.